Department of Pharmacokinetics and Physical Pharmacy
Head: Professor Elżbieta Wyska PhD
Science Group Supervisors: Małgorzata Szafarz PhD and Artur Świerczek PhD
Achievements:
ESCP 52nd Symposium: Implementing and Scaling Sustainable Clinical Pharmacy
21–23 November 2024, Kraków
“LC-MS/MS analytical methods for quantification of three anticancer drugs in VAMS – application to TDM in pediatric population.”
Karolina Boś, Małgorzata Szafarz, Katarzyna Szymbor, Wojciech Czogała, Iwona Świerczek-Skierawska, Szymon Skoczeń, Walentyna Balwierz, Elżbieta Wyska
1st Place in Poster Session – 1st Symposium of the Polish Society of Clinical Pharmacy
28–29 September 2023, Warsaw
“Optimization of vancomycin dosing in pediatric patients with complicated or drug-resistant pneumonia”
Krzysztof Klimza, Małgorzata Szafarz, Ewa Cichocka-Jarosz, Izabella Głodzik, Barnaba Piwowarczyk, Elżbieta Wyska
Conference: 11th Congress of the Polish Society of Pediatric Oncology and Hematology
2–4 June 2022, Bydgoszcz
“Optimization of amikacin dosing in pediatric oncology patients”
Małgorzata Szafarz, Krzysztof Klimza, Wojciech Czogała, Walentyna Balwierz, Szymon Skoczeń
Session of Pharmacy and Clinical Pharmacology
25–26 April 2018, Katowice
“Preliminary pharmacokinetic studies of new compound KSK19 with potential pro-cognitive pharmacological activity”
Filip A. Fedak, Katarzyna Nowak, Katarzyna Szczepańska
12th Copernican International Young Scientists Conference
28–29 June 2018, Toruń
“Tissue distribution, metabolism and hepatic elimination study of new compound KSK19 with potential pro-cognitive pharmacological activity”
Katarzyna Nowak, Filip A. Fedak, Katarzyna Szczepańska, Małgorzata Szafarz
“Isolated mouse hepatocytes as a tool for assessing hepatic uptake and metabolic clearance of drugs”
Filip A. Fedak, Katarzyna Nowak, Małgorzata Szafarz
Student Grant (2016–2017)
“Evaluation of physicochemical and pharmacokinetic parameters of new phosphodiesterase 4 and 7 inhibitors.”